Though intravenously administrated NMO-IgG was readily visualized in AQP4-expressing cells throughout the periphery, with one exception it was undetectable throughout CNS tissues including brain, spinal cord, optic nerve and retina, despite the sensitivity and specificity of the anti-human fluorescent secondary antibody. This evidence concerns the gene AQP4 and neuromyelitis optica.